Schwab M - Search Results

1

MYCN in neuronal tumours.

Schwab M. Schwab M. Cancer Lett. 2004 Feb 20;204(2):179-87. doi: 10.1016/S0304-3835(03)00454-3. Cancer Lett. 2004. PMID: 15013217 Review.

2

The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers.

Blumrich A, Zapatka M, Brueckner LM, Zheglo D, Schwab M, Savelyeva L. Blumrich A, et al. Among authors: schwab m. Hum Mol Genet. 2011 Apr 15;20(8):1488-501. doi: 10.1093/hmg/ddr027. Epub 2011 Jan 21. Hum Mol Genet. 2011. PMID: 21258086

3

Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.

Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, Beisel C, Gogolin S, Fischer M, Henrich KO, Ehemann V, Gillespie P, Schwab M, Westermann F. Muth D, et al. Among authors: schwab m. Cancer Res. 2010 May 1;70(9):3791-802. doi: 10.1158/0008-5472.CAN-09-1245. Epub 2010 Apr 27. Cancer Res. 2010. PMID: 20424123

4

Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.

Eckerle I, Muth D, Batzler J, Henrich KO, Lutz W, Fischer M, Witt O, Schwab M, Westermann F. Eckerle I, et al. Among authors: schwab m. Cancer Lett. 2009 Nov 18;285(1):99-107. doi: 10.1016/j.canlet.2009.05.007. Epub 2009 Jun 3. Cancer Lett. 2009. PMID: 19497660

5

Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.

Paffhausen T, Schwab M, Westermann F. Paffhausen T, et al. Among authors: schwab m. Cancer Lett. 2007 May 18;250(1):17-24. doi: 10.1016/j.canlet.2006.09.010. Epub 2006 Dec 4. Cancer Lett. 2007. PMID: 17141950

6

Neuroblastoma: biology and molecular and chromosomal pathology.

Schwab M, Westermann F, Hero B, Berthold F. Schwab M, et al. Lancet Oncol. 2003 Aug;4(8):472-80. doi: 10.1016/s1470-2045(03)01166-5. Lancet Oncol. 2003. PMID: 12901961 Review.

7

Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma.

Berwanger B, Hartmann O, Bergmann E, Bernard S, Nielsen D, Krause M, Kartal A, Flynn D, Wiedemeyer R, Schwab M, Schäfer H, Christiansen H, Eilers M. Berwanger B, et al. Among authors: schwab m. Cancer Cell. 2002 Nov;2(5):377-86. doi: 10.1016/s1535-6108(02)00179-4. Cancer Cell. 2002. PMID: 12450793

8

Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.

Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F. Spitz R, et al. Among authors: schwab m. Genes Chromosomes Cancer. 2002 Jul;34(3):299-305. doi: 10.1002/gcc.10070. Genes Chromosomes Cancer. 2002. PMID: 12007190

9

Ataxin-2 promotes apoptosis of human neuroblastoma cells.

Wiedemeyer R, Westermann F, Wittke I, Nowock J, Schwab M. Wiedemeyer R, et al. Among authors: schwab m. Oncogene. 2003 Jan 23;22(3):401-11. doi: 10.1038/sj.onc.1206150. Oncogene. 2003. PMID: 12545161

10

Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.

Dreidax D, Gogolin S, Schroeder C, Muth D, Brueckner LM, Hess EM, Zapatka M, Theißen J, Fischer M, Ehemann V, Schwab M, Savelyeva L, Westermann F. Dreidax D, et al. Among authors: schwab m. Hum Mol Genet. 2013 May 1;22(9):1735-45. doi: 10.1093/hmg/ddt020. Epub 2013 Jan 23. Hum Mol Genet. 2013. PMID: 23343716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results